Swine composite interferon used for emergent prevention for African swine fever

An African swine fever and compound technology, applied in the field of porcine compound interferon, can solve the problems of inability to replicate the virus and inability to combine viral nucleic acids, and achieve the effects of good immune protection, long storage period, and significant application and promotion value

Active Publication Date: 2019-10-22
INST OF MICROBIOLOGY - CHINESE ACAD OF SCI
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This technology provides an improved version that can protect against both bacterial or viral diseases caused by Swinweed saliva virus. It also lasts well over time without losing its ability to fight off other harmful organisms like this disease causing it's spreading throughout Africa.

Problems solved by technology

This patented technical solution described in the current text describes how certain diseases like AFI have been identified around the globe due to lack of effective treatment options available through traditional methods. In addition, some countries face challenges from biological terrorism threatening their livelihood while maintaining strict regulations regarding slaughter rates and social security measures associated with these events.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Swine composite interferon used for emergent prevention for African swine fever

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Embodiment 1, the preparation of protein solution

[0035] 1. Preparation of recombinant plasmids

[0036] The double-stranded DNA molecule shown in nucleotides 4-435 of Sequence 2 in the sequence listing was inserted between the NdeI and XhoI restriction sites of the pET30a(+) vector to obtain recombinant plasmid I. The recombinant plasmid I has an open reading frame shown in sequence 2 of the sequence listing, and expresses the protein shown in sequence 1 of the sequence listing.

[0037] The double-stranded DNA molecule shown in nucleotides 4-948 of Sequence 4 in the sequence listing was inserted between the NdeI and XhoI restriction sites of the pET30a(+) vector to obtain recombinant plasmid II. The recombinant plasmid II has an open reading frame shown in sequence 4 of the sequence listing, and expresses the protein shown in sequence 3 of the sequence listing.

[0038] Insert the double-stranded DNA molecule shown in nucleotides 4-552 of Sequence 6 in the sequence l

Embodiment 2

[0080] Embodiment 2, detect interferon activity

[0081] The test solutions were: the protein I solution, protein II solution, protein III solution or protein IV solution prepared in Example 1, all of which were freshly prepared.

[0082] 1. Cell plating

[0083] Get well-grown PK-15 cells, digest with trypsin, and then suspend with DMEM medium containing 100 U / mL penicillin, 100 U / mL streptomycin and 10% (volume ratio) FBS to obtain a cell concentration of 1 × 10 6 cell suspension per mL, add the cell suspension to a 96-well cell culture plate (100 μl / well), and then place it at 37°C with 5% CO 2 Cultured in a static incubator for 8 hours (to become a monolayer of cells).

[0084] 2. Take the test solution and dilute to 25 times volume, 250 times volume, 2500 times volume or 25000 times volume with DMEM medium containing 10% (volume ratio) FBS to obtain each dilution.

[0085] 3. Take the cell culture plate that completed step 1, suck and discard the supernatant; add th

Embodiment 3

[0094] Embodiment 3, the stability of protein solution

[0095] The freshly prepared protein I solution, protein II solution, protein III solution or protein IV solution prepared in Example 1 was placed at room temperature for 3 months, and then used as the test solution (10 parallel treatments were set for each solution).

[0096] 1. Morphological observation

[0097] The protein Ⅰ solution, protein Ⅱ solution and protein Ⅲ solution all became turbid after standing at room temperature for 3 months.

[0098] The protein Ⅳ solution remained clear after 3 months at room temperature.

[0099] 2. Detection of interferon activity

[0100] Method is with embodiment 2. The results are averaged.

[0101] The interferon titer of the protein Ⅰ solution after 3 months at room temperature was 8.2×10 5 U / ml, 48% of freshly prepared.

[0102] The interferon titer of the protein Ⅱ solution after 3 months at room temperature was 3.3×10 5 U / ml, 43% of freshly prepared.

[0103] The in

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a swine composite interferon used for emergent prevention for the African swine fever. A protein (swine gamma interferon-connecting peptide-swine antibacterial peptide segmentfusion protein) is provided and shown in a sequence 7 of a sequence table. A gene coding the protein also belongs to the protection range of the swine composite interferon. The invention further provides a compound which comprises the protein and lentinan; in the compound, every 1.0*10<-9> mol of protein is matched with 15 micrograms of lentinan. The invention further relates to application of theprotein or the compound in preparation of an African swine fever vaccine. The invention further provides the African swine fever vaccine. The active component of the African swine fever vaccine is the protein or the compound. The protein and the compound have a good immune protection effect and are high in stability (the protein and the compound can be preserved at the room temperature and are long in preservation period). The swine composite interferon has high application and popularization value in prevention and control over the African swine fever.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner INST OF MICROBIOLOGY - CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products